Cardinal Health Long Term Debt 2010-2023 | CAH

Cardinal Health long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  • Cardinal Health long term debt for the quarter ending December 31, 2023 was $3.535B, a 24.55% decline year-over-year.
  • Cardinal Health long term debt for 2023 was $3.909B, a 17.44% decline from 2022.
  • Cardinal Health long term debt for 2022 was $4.735B, a 11.74% decline from 2021.
  • Cardinal Health long term debt for 2021 was $5.365B, a 20.69% decline from 2020.
Cardinal Health Annual Long Term Debt
(Millions of US $)
2023 $3,909
2022 $4,735
2021 $5,365
2020 $6,765
2019 $7,579
2018 $8,012
2017 $9,068
2016 $4,952
2015 $5,211
2014 $3,171
2013 $3,686
2012 $2,418
2011 $2,175
2010 $1,896
2009 $3,272
Cardinal Health Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $3,535
2023-09-30 $3,890
2023-06-30 $3,909
2023-03-31 $4,708
2022-12-31 $4,685
2022-09-30 $4,689
2022-06-30 $4,735
2022-03-31 $4,751
2021-12-31 $5,342
2021-09-30 $5,353
2021-06-30 $5,365
2021-03-31 $6,715
2020-12-31 $6,720
2020-09-30 $6,728
2020-06-30 $6,765
2020-03-31 $6,754
2019-12-31 $6,742
2019-09-30 $7,360
2019-06-30 $7,579
2019-03-31 $7,629
2018-12-31 $7,599
2018-09-30 $7,999
2018-06-30 $8,012
2018-03-31 $9,027
2017-12-31 $9,057
2017-09-30 $9,068
2017-06-30 $9,068
2017-03-31 $4,854
2016-12-31 $4,859
2016-09-30 $4,916
2016-06-30 $4,952
2016-03-31 $5,195
2015-12-31 $5,171
2015-09-30 $5,231
2015-06-30 $5,211
2015-03-31 $3,720
2014-12-31 $3,706
2014-09-30 $3,164
2014-06-30 $3,171
2014-03-31 $3,679
2013-12-31 $3,679
2013-09-30 $3,693
2013-06-30 $3,686
2013-03-31 $3,714
2012-12-31 $2,423
2012-09-30 $2,408
2012-06-30 $2,418
2012-03-31 $2,208
2011-12-31 $2,211
2011-09-30 $2,195
2011-06-30 $2,175
2011-03-31 $2,362
2010-12-31 $2,380
2010-09-30 $1,906
2010-06-30 $1,896
2010-03-31 $1,876
2009-12-31 $2,099
2009-09-30 $2,104
2009-06-30 $3,272
2009-03-31 $3,303
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $25.885B $205.012B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
West Pharmaceutical Services (WST) United States $28.373B 47.97
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Labcorp (LH) United States $17.372B 14.84
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
Merit Medical Systems (MMSI) United States $4.272B 24.44
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00